The Wall Street Journal
@wsj·6.6M subscribers·28.9K videos
FDA OKs Drug for Multiple Sclerosis
Posted
March 29, 2017
Views
2,408
Likes
24
Comments
12
Engagement
1.50%
March 29, 2017
2,408
24
12
1.50%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
4:21Now PlayingThe FDA has approved Ocrevus, a drug from Genentech and the first treatment for the most severe form of Multiple Sclerosis. WSJ's Tom Burton and Tanya Rivero discuss the nature of the medication and its high cost. Photo: AP
Subscribe to the WSJ channel here:
More from the Wall Street Journal:
Visit WSJ.com
Follow WSJ on Facebook
Follow WSJ on Google+
Follow WSJ on Twitter
Follow WSJ on Instagram
Follow WSJ on Pinterest
Don’t miss a WSJ video, subscribe here
More from the Wall Street Journal:
Visit WSJ.com
Visit the WSJ Video Center
On Facebook
On Snapchat
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
